Home › Biotech Deserves A Piece Of Every Dividend Growth Portfolio
 

Keywords :   


Biotech Deserves A Piece Of Every Dividend Growth Portfolio

2016-01-26 07:14:29| Biotech - Topix.net

Taking into account their projected EPS growth rates and potential for dividend growth, both companies, but in particular Gilead Sciences, are attractively valued relative to the market. Amgen became a pioneer in the biotech world when it became the first large biotech stock to begin paying a regular dividend in 2011.

Tags: growth piece portfolio biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »